Maintenance therapy with alternating azacitidine and lenalidomide in elderly fit patients with poor prognosis acute myeloid leukemia: a phase II multicentre FILO trial.

Hunault-Berger M, Maillard N, Himberlin C, Recher C, Schmidt-Tanguy A, Choufi B, Bonmati C, Carré M, Couturier MA, Daguindau E, Marolleau JP, Orsini-Piocelle F, Delaunay J, Tavernier E, Lissandre S, Ojeda-Uribe M, Sanhes L, Sutton L, Banos A, Fornecker LM, Bernard M, Bouscary D, Saad A, Puyade M, Rouillé V, Luquet I, Béné MC, Hamel JF, Dreyfus F, Ifrah N, Pigneux A

Open source

DOI
10.1038/bcj.2017.50
Published
2017 Jun 2
Container
Blood cancer journal
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/bcj.2017.50,
  title = {Maintenance therapy with alternating azacitidine and lenalidomide in elderly fit patients with poor prognosis acute myeloid leukemia: a phase II multicentre FILO trial.},
  author = {Hunault-Berger M and Maillard N and Himberlin C and Recher C and Schmidt-Tanguy A and Choufi B and Bonmati C and Carré M and Couturier MA and Daguindau E and Marolleau JP and Orsini-Piocelle F and Delaunay J and Tavernier E and Lissandre S and Ojeda-Uribe M and Sanhes L and Sutton L and Banos A and Fornecker LM and Bernard M and Bouscary D and Saad A and Puyade M and Rouillé V and Luquet I and Béné MC and Hamel JF and Dreyfus F and Ifrah N and Pigneux A},
  year = {2017},
  journal = {Blood cancer journal},
  doi = {10.1038/bcj.2017.50},
  url = {https://doi.org/10.1038/bcj.2017.50}
}

RIS

TY  - JOUR
TI  - Maintenance therapy with alternating azacitidine and lenalidomide in elderly fit patients with poor prognosis acute myeloid leukemia: a phase II multicentre FILO trial.
AU  - Hunault-Berger M
AU  - Maillard N
AU  - Himberlin C
AU  - Recher C
AU  - Schmidt-Tanguy A
AU  - Choufi B
AU  - Bonmati C
AU  - Carré M
AU  - Couturier MA
AU  - Daguindau E
AU  - Marolleau JP
AU  - Orsini-Piocelle F
AU  - Delaunay J
AU  - Tavernier E
AU  - Lissandre S
AU  - Ojeda-Uribe M
AU  - Sanhes L
AU  - Sutton L
AU  - Banos A
AU  - Fornecker LM
AU  - Bernard M
AU  - Bouscary D
AU  - Saad A
AU  - Puyade M
AU  - Rouillé V
AU  - Luquet I
AU  - Béné MC
AU  - Hamel JF
AU  - Dreyfus F
AU  - Ifrah N
AU  - Pigneux A
PY  - 2017
JO  - Blood cancer journal
DO  - 10.1038/bcj.2017.50
UR  - https://doi.org/10.1038/bcj.2017.50
ER  - 

APA

M, H., N, M., C, H., C, R., A, S., B, C., C, B., M, C., MA, C., E, D., JP, M., F, O., J, D., E, T., S, L., M, O., L, S., L, S., A, B., LM, F., M, B., D, B., A, S., M, P., V, R., I, L., MC, B., JF, H., F, D., N, I., & A, P. (2017). Maintenance therapy with alternating azacitidine and lenalidomide in elderly fit patients with poor prognosis acute myeloid leukemia: a phase II multicentre FILO trial.. Blood cancer journal. https://doi.org/10.1038/bcj.2017.50

Source records